Helping Complex Patients Age in Place
In this Interview
Paul Kusserow is the President and Chief Executive Officer for Amedisys and a member of its Board of Directors. A healthcare industry veteran with deep expertise in driving growth strategies, previously served as President and Vice Chairman of Alignment Healthcare, Inc. and as Senior Vice President, Chief Strategy, Innovations and Corporate Development Officer of Humana, Inc. Mr. Kusserow’s experience also includes time as Managing Director and Chief Investment Officer of the Ziegler HealthVest Fund; Managing Director of San Ysidro Capital Partners, L.L.C.; and Managing Partner of Roaring Mountain, L.L.C. He began his healthcare career with Tenet Healthcare Corporation. Kusserow is on the boards of Connecture (Nasdaq: CNXR), Picwell, New Century Health and Matrix Medical Network. Prior to Tenet, Mr. Kusserow was a consultant at McKinsey and Company, Inc. Mr. Kusserow also serves on the Board of Directors for Dream Foundation. Mr. Kusserow received his Bachelor of Arts from Wesleyan University, where he was a member of Phi Beta Kappa, and his Master of Arts from Oxford University, where he was a Rhodes Scholar.
Blake Marggraff co-founded Epharmix, the leader in evidence-based remote patient monitoring. Epharmix helps risk-bearing healthcare organizations succeed in value-based care by enabling care managers to communicate with their high and rising-risk patients more efficiently. Epharmix sends automated, proactive SMS texts and calls with disease-specific messages to the patient's own phone to gather key patient biometrics and self-reported symptoms. This information is run through Epharmix algorithms providing relevant actionable alerts and trending so that clinical teams deliver timely outreach and prevent an unnecessary ED visit or exacerbation. In addition to his passion for transforming healthcare through Epharmix, Blake is a Board Member of the Institute for Family Medicine.